Exor N.V.

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Editorial infographic about Tata Motors raising its recommended cash offer for Iveco Group to €14.40 per share, showing a commercial truck background and key highlights including the roughly €81 million increase and the deal’s status as Tata Motors’ biggest overseas commercial vehicle acquisition.

Tata Motors raises Iveco takeover offer to €14.40 as €3.91bn deal nears decisive vote

Tata Motors has lifted its recommended cash offer for Iveco Group to €14.40 per share, adding roughly €81 million to the transaction as the Indian truckmaker pushes its largest overseas commercial vehicle acquisition toward completion.

byPallavi Madhiraju

October 10, 2026

Representative image of Italy’s historic La Stampa newspaper in Turin as GEDI Gruppo Editoriale agrees to sell the publication to Società Athesis Editrice, ending the Agnelli family’s 100-year ownership of the Italian daily.

The end of a dynasty: Why the Agnelli family is finally letting go of La Stampa

GEDI agrees to sell La Stampa to SAE, ending the Agnelli family’s 100-year ownership. Discover what the deal means for Italy’s media landscape.

byPallavi Madhiraju

March 7, 2026

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Tata Motors raises Iveco takeover offer to €14.40 as €3.91bn deal nears decisive vote

The end of a dynasty: Why the Agnelli family is finally letting go of La Stampa

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

SAMILBIO expands Chaeyun skincare with two November launches as K-beauty exports reach $11.1bn

Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?

Haleon (HLN) near 319p: Does a 15% share-price crash make its valuation attractive after the growth downgrade?

Ethan Allen will split CEO and chair roles, but who gets to choose Farooq Kathwari’s successor?